Protective Effect of MK801 in Experimental Brain Injury
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The effect of a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, MK801, was studied in a model of closed head injury in rats. Head trauma (HT) was induced over the left cerebral hemisphere by a calibrated weight-drop device. One or 3 h later, MK801 in saline was given i.p. in a single bolus of either 1, 3, or 10 mg/kg. The rats were killed at 4, 24, or 48 h after HT. Cortical tissue samples were taken from the injured zone and from the corresponding region of the contralateral hemisphere and analyzed for specific gravity (SG) by linear gradient columns. The neurological status of the traumatized rats was evaluated by a neurological severity score (NSS) 1 h after trauma and just before death. Pathological evaluation, based on size and severity of the lesion, was performed 24 and 48 h after HT on control and MK801-treated rats. A dose of 3 mg/kg MK801 given 1 h after trauma effectively prevented the reduction in tissue SG only at 24 h. The NSS could not be evaluated at 24 h after trauma because of the sedating effect of the drug. At 48 h posttrauma, however, the drug significantly improved the neurological state of the rats. No significant difference was found in the pathological score between treated and untreated rats. The results demonstrate neuroprotective properties of MK801, as expressed in two different variables--reduced edema formation and improved neurological recovery after HT. These findings support existing evidence that pharmacological intervention with NMDA receptor antagonist after head injury may be of clinical value in the management of head-injured patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Role of Excitatory Amino Acids and NMDA Receptors in Traumatic Brain Injury
Faden, A. I., Demediuk, P., Panter, S. S., & Vink, R. (1989) · Science · doi:10.1126/science.2567056 · Cited by 1,508 · cited 1×
“Traumatic brain injury also was shown to cause marked elevation in glutamate (Katayama et al., 1988; Faden et al., 1989).”
Cited by
Bramlett, H. M., & Dietrich, W. D. (2015) · Journal of Neurotrauma · doi:10.1089/neu.2014.3352 · Cited by 550
Factors affecting excitatory amino acid release following severe human head injury
Bullock, R., Zauner, A., Woodward, J. J., Myseros, J., Choi, S. C., Ward, J. D., Marmarou, A., & Young, H. F. (1998) · Journal of Neurosurgery · doi:10.3171/jns.1998.89.4.0507 · Cited by 526
Traumatic Brain Injury‐Induced Excitotoxicity Assessed in a Controlled Cortical Impact Model
Palmer, A. M., Marion, D. W., Botscheller, M. L., Swedlow, P. E., Styren, S. D., & DeKosky, S. T. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07437.x · Cited by 411
Obrenovitch, T. P., & Urenjak, J. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00049-4 · Cited by 307
Novel Pharmacologic Strategies in the Treatment of Experimental Traumatic Brain Injury: 1998
McINTOSH, T. K., JUHLER, M., & WIELOCH, T. (1998) · Journal of Neurotrauma · doi:10.1089/neu.1998.15.731 · Cited by 298
Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury?
Obrenovitch, T. P., & Urenjak, J. (1997) · Journal of Neurotrauma · doi:10.1089/neu.1997.14.677 · Cited by 205
DeWitt, D. S., & Prough, D. S. (2003) · Journal of Neurotrauma · doi:10.1089/089771503322385755 · Cited by 195
“The competitive NMDA antagonist CP101,606 (Okiyama et al., 1997) and the noncompetitive NMDA antagonist MK801 (Shapira et al., 1990) reduced cerebral edema after TBI, suggesting that activation of glutamate receptors may contribute to trauma-induced increases in BBB permeability.”
Ethanol Reduces Metabolic Uncoupling Following Experimental Head Injury
KELLY, D. F., KOZLOWSKI, D. A., HADDAD, E., ECHIVERRI, A., HOVDA, D. A., & LEE, S. M. (2000) · Journal of Neurotrauma · doi:10.1089/neu.2000.17.261 · Cited by 82
Metadata
- Authors
- SHAPIRA, Y., YADID, G., COTEV, S., NISKA, A., & SHOHAMI, E.
- Venue
- Journal of Neurotrauma
- Publisher
- SAGE Publications
- Published
- 1990-01
- Volume
- 7
- Issue
- 3
- Pages
- 131-139
- ISSN
- 0897-7151 (ISSN-L)
- 1557-9042
- OpenAlex
- W2002848242
- Cited by
- 126
- References
- 1
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.